{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-001111","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.622944+00:00","generated_at":"2026-06-09T06:49:58.514452+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IGC Pharma enters $60M ATM equity offering with A.G.P./Alliance Global Partners","bullets":["On Oct 27, 2023, IGC Pharma entered an ATM sales agreement with A.G.P./Alliance Global Partners to sell up to $60M of common stock.","A.G.P. will receive a 3% commission on gross proceeds; the company reimburses up to $40K legal fees and $10K annual maintenance.","The prior ATM agreement with The Benchmark Company (Jan 2021) was terminated.","Board initially reserved shares based on Oct 25 closing price of $0.29 per share.","Agreement terminates upon sale of all shares, or by either party with 5 days' notice, or registration statement expiry."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-001111","json":"https://secwatch.observer/filing/0001185185-23-001111.json","markdown":"https://secwatch.observer/filing/0001185185-23-001111.md","text":"https://secwatch.observer/filing/0001185185-23-001111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/0001185185-23-001111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/igcpharma20231027_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:49:58.514452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac2b5f864d4236a6cbfde4ebeba0255b833f2dfa","claim":"IGC Pharma, Inc. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at up to $60 million.","evidence_excerpt":"IGC Pharma, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with A.G.P./Alliance Global Partners (the “Agent”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/0001185185-23-001111-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Value","value":"up to $60 million"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}